secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acurx Pharmaceuticals, Inc. (ACXP)
CIK:        0001736243
Form:       8-K
Filed at:   2025-09-22T23:59:59+00:00
Accession:  0001104659-25-092166
Event type: other
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acurx increases authorized common stock from 200 million to 250 million shares
------------------------------------------------------------------------------

- Stockholders approved amendment at special meeting on September 16, 2025.
- Authorized common stock increased from 200,000,000 to 250,000,000 shares.
- Amendment filed with Delaware Secretary of State on September 22, 2025, effective immediately.
- Shares may be used for future capital raising, acquisitions, or other corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1736243/000110465925092166/0001104659-25-092166-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1736243/000110465925092166/tm2526666d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-092166

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer